Healthcare and life sciences in Germany

Includes the practice areas often described as life sciences and healthcare. In addition to the regulatory core area of the healthcare sector, transactions in the healthcare sector and expertise in other industry-specific issues are also taken into account, including a list of the strongest law firms in pharmaceutical advertising law. The ranking also includes two listings of the strongest firms in regulatory and transaction-related advice.

Baker McKenzie

Baker McKenzie 's healthcare and life sciences group impresses with its multidisciplinary expertise and strong international orientation. The German group is a renowned player in the market due to practice head Thilo Räpple's regulatory pharmaceutical and drug advertising law expertise. His team receives additional support from the strong procurement law practice led by Marc Gabriel as well as the antitrust experts headed by Christian Burholt. With additional capabilities in the transactional space and the experienced colleagues from the green area, the firm offers full-service advice on complex mandates. Covid-19 naturally played a major role in 2020, especially in matters pertaining to contract law such as cooperation and supply agreements, but also the medical products sector. The team has experience in advising on market access issues and also on the digitisation of the healthcare system, for example on digital healthcare apps. Another growth area was the financing practice in the venture capital space, particularly the biotechnology sector.

Practice head(s):

Thilo Räpple


‘Very diverse team headed by the brilliant and extremely experienced Thilo Räpple, who always works very pragmatically and offers practical solutions.’

‘Thilo Räpple is very experienced and always looking for pragmatic solutions.’

‘The team is well networked with regulatory experts on competition law and antitrust law. Even if the colleagues are not based at the same location, the network is very good. Thanks to well-known clients, the know-how comes from practice.’

‘Primarily Christian Burholt should be mentioned here. He combines healthcare law expertise with European antitrust law know-how.’

‘Internationally integrated, very good knowledge of the pharmaceutical and biotech industry in Germany/EU.’

‘Thilo Räpple: Very good advisor, holistic legal and economic advice.’

‘Christian Burholt offers outstanding expertise!’

Key clients

Allecra Therapeutics


Chr. Hansen Holding A/S

Bayer AG

Sino Biopharmaceutical


Casdin Capital

Servier Monde

Work highlights

  • Advising Chr. Hansen Holding A/S on the acquisition of all shares in Jennewein Biotechnologie GmbH for a purchase price of around €310 million.
  • Advised CureVac on several collaboration agreements and service agreements, including with Bayer and GSK to support the development and delivery of the Covid-19 vaccine.
  • AdvisingServing Monde on the acquisition of Agios Pharmaceuticals’ oncology business, including a commercial, clinical and research-based oncology portfolio and employees, for up to $2 billion plus royalties.

Clifford Chance

In 2020, Clifford Chance was extensively active in matters pertaining to the Covid-19 pandemic, the digitisation of the healthcare sector and the regulatory framework for medicinal cannabis-based products. The team advised on vaccine development and distribution agreements, the development of health platforms and digital health applications, as well as product compliance issues. Other growth areas include compliance-related advice on social corporate governance (ESG) standards, including supply chain requirements, strategic contentious pharmaceutical advertising issues and transactional matters in the private equity space. Headed by the renowned Peter Dieners and Ulrich Reese, both in Düsseldorf, the internationally-oriented team is among the top firms in Germany due to its expertise in the healthcare and life sciences sector and thus regularly receives instructions from the German government as well as industry associations. The full-service advice, evident in the close cooperation with experts in data protection and IT, antitrust law, litigation and real estate law, offers comprehensive support for clients. Another key contact is Gunnar Sachs, he regularly advises the German government and is specialised in digitisation as well as IP matters.

Practice head(s):

Peter Dieners; Ulrich Reese


‘Very good division of activities between partners and associates, which makes the respective work result appear to be of one piece.’

‘Ulrich Reese has an impressive understanding of medical and biological issues, which forms the basis for advising and then representing in court proceedings. Crystal-clear analysis, concentration on the essentials and impressive experience in drug advertising combined with eloquence in pleadings and in court characterize his work.’

‘High level of technical expertise, strategic and very analytical thinking, which allows solutions to be developed quickly. Various departments and expertise are used within the law firm.’

‘Ulrich Reese: Always approachable, gets back to you quickly. Good problem solutions are developed on the basis of his technical expertise and his analytical thinking.’

‘Able to efficiently process and get to the heart of complex issues and issues in the healthcare market.’

‘Peter Dieners has an overview of the entire healthcare market. Ulrich Reese works on special topics with the necessary depth. Both are perfect in client communication.’

‘Unique: the law firm appears uniform to the outside world, very coordinated and collegial; Clifford Chance covers all relevant legal and compliance areas for the healthcare/pharmaceutical industry and has the greatest possible expertise; very collegial dealings with clients: advice on a human eye level.’

‘Gunnar Sachs:Extreme industry knowledge of the healthcare/pharmaceutical market; very good accessibility; identifies with the clients and sits on the client’s projects. Looks for and finds creative contract models and innovative solutions for pharmaceutical projects; highly competent, solution-oriented advice, pragmatic with appropriate willingness to take risks; human; sympathetic, humorous.’

‘Good internal agreements and cooperation – everyone involved in the project is involved. Fast response times, competent contact persons, also for special questions.’

‘Good accessibility, cost-benefit orientation, mostly very realistic assessment of the situation. High level of expertise from Gunnar Sachs. Good support in day-2-day business from Caroline Giesen.’

Hogan Lovells International LLP

Due to its sizeable and highly specialised German team, Hogan Lovells International LLP has been at the top for years. Regulatory specialist  Jörg Schickert (Munich) is one of the most renowned experts in the country and, together with Arne Thiermann (Hamburg), advises on novel therapies, including stem cell therapy, gene therapy and CAR-T cell therapy. Tanja Eisenblätter (Hamburg) handles pharmaceutical advertising matters and leads one of the most prominent German litigation practices, which was particularly active in 2020. Other advisory topics include digital health issues and the digitisation of the healthcare sector, with regular cross-border instructions on the management of strategic alliances and licensing agreements between pharmaceutical and IT companies. The firm’s venture and growth capital expertise is also put to good use in this area. The corporate team, headed by Lutz Angerer (Munich), is increasingly active for private equity houses in other license transactions and M&A matters. Ina Brock , Sebastian Lach and Matthias Schweiger in Munich mainly advise on product liability and compliance. In 2020, the advice on matters pertaining to therapeutic and medical devices notably increased due to Covid-19. The large patent law practice, headed by Andreas von Falck (Düsseldorf) constitutes another core strength. Due to the international positioning of the firm, the group receives regular instructions in the pan-European and global context, in addition to its established transactional cooperation with the US colleagues. Patent specialist Stephan Neuhaus joined Allen & Overy LLP in May 2021.


‘Outstanding life sciences expertise, business acumen, solution-oriented.’

‘Jörg Schickert: Excellent life sciences knowledge, very involved, economically thinking, pragmatic solutions. Very responsive and with broad knowledge of healthcare law, regulatory requirements and business law.’

‘Tina Welter-Birk: Very good knowledge of public health law, reimbursement law (social security law).’

‘Arne Thiermann: Fantastic regulatory knowledge.’

Ina Brock: professional, experienced, international reputation.’

‘Lutz Angerer: Very good knowledge and experience in M&A and corporate.’

‘International standing, know-how, regulatory experience.’

‘Arne Thiermann: Committed, lots of regulatory know-how.’

‘Very good knowledge of the legal field, business and client-oriented approach.’

‘Jörg Schickert uses his broad knowledge of the industry to advise his clients in a pragmatic and business-oriented manner and is very efficient and punctual.’

‘Arne Thiermann is characterized by a high level of professional competence, pragmatism and a clear focus on the big picture. A sharp focus coupled with pragmatism means that what we consider to be very important points in negotiations are always achieved without this leading to complex negotiations. This is an essential quality of a very good lawyer in order to obtain important contracts of high quality and in one’s own interest, but at the same time at reasonable costs.’

Key clients

Bristol-Myers Squibb

Daiichi Sankyo


Baxtern International

Eli Lilly


Compass Pathways Ltd

Vifor (International) AG

Merck & Co. Inc.

Bluebird Bio Inc.

Bird & Bird LLP

In addition to a strong patent law practice, which fields practice head Boris Kreye in Munich, Bird & Bird LLP offers an established procurement law team with Alexander Csaki (Munich) as the key figure. Among the core topics are digital health matters, in particular advising on IT and outsourcing contracts; here, the group regularly advises in joint cooperation with data protection lawyers and e-commerce specialists. The firm's employment law, transactional, antitrust and regulatory expertise further complement the advisory offering. Miriam Ballhausen (Hamburg; technology transactions, data-based projects, software development), Stephan Waldheim (Düsseldorf; antitrust law) and Marc Grunwald (Munich; patent law) made partner in the months between November 2020 and May 2021. Anna Wolters-Höhne left the firm in May 2021.

Practice head(s):

Boris Kreye


‘Fast, good, on-the-spot.’

Key clients

Aphria Inc.

B. Braun Melsungen


Dr. Loges + Co. GmbH

Edwards Lifesciences

Elixinol Global Ltd

Ellab A/S

Fisher Paykel



Guardant Health Inc.

Henry Schein


KORIAN Deutschland AG

LenioBio GmbH

Materia Ventures

Merck KgaA / Ares Trading S.A.


Northern Green Canada Inc

Omnicell Technologies



Serum Institute of India Pvt. Ltd



Tillomed Pharma GmbH

Universitätklinikum Gießen und Marburg


Ypsomed AG


Work highlights

  • Advising a drug manufacturer on a successful review procedure for the procurement of drugs from the AOKs.
  • Representing Edwards Lifesciences in several proceedings regarding various patents.
  • First consulting project of the University Hospital Gießen and Marburg on the Covid-19 app for the initial assessment of symptoms of the disease.


CMS advises on regulatory issues, particularly pharmaceutical and medical device manufacturers on market access issues. In addition to corona-related matters in 2020, the team increasingly advised providers of medicinal cannabis products. The firm’s expertise in pharmaceutical advertising and product liability contributes to its good reputation. App developers, including providers of digital health applications, start-ups and investors are supported with digital health matters and the team’s data protection expertise complements the advice in the digitisation context. In the corporate space, advisory capacities pertaining to investments in medical care centers expanded in 2020, with increased instructions from clinics, in addition to private equity houses and other investors. The group also offers support with transactional issues such as joint ventures, takeovers and share purchases. Jens Wagner in Hamburg heads the team. Klaus Ikas and Rainer Kienast retired in 2020.

Practice head(s):

Jens Wagner


‘Excellent industry knowledge; excellent knowledge and wealth of experience in the relevant legal matter; uncomplicated, pragmatic and efficient networking with other practice groups when required; extraordinarily honest team and exemplary communication and dealing with clients.’

‘Roland Wiring: Long-term cooperation; excellent knowledge of the industry and excellent knowledge as well as a wealth of experience in the relevant legal matter; pragmatic, solution-oriented and efficient advice and representation; extraordinarily pleasant personal contact.’

‘CMS is one of our key external legal advisors. We particularly appreciate the pragmatic and practice-oriented approach, the service orientation, the very high professional quality and the distinctive industry expertise.

‘We value Jens Wagner both as a tough litigator and as a very competent advisor and negotiator. Due to his excellent industry expertise and his team orientation, he was able to build a powerful life sciences team around the younger partners and counsel.’

‘Roland Wiring impresses above all with his in-depth industry expertise, excellent legal know-how and extraordinarily high level of service. We value him in particular as a clever litigator, as a strategically thinking and at the same time pragmatic consultant in the fields of compliance and regulatory matters and as an expert on digitization issues.’

‘Broadly positioned. High know-how. Flexible and very professional.’

‘Jörn Witt is committed, professional, experienced and reliable.’

‘Good network for special questions.’

‘Unpretentious and pragmatic, close to implementable/practical solution proposals, uncomplicated/short-term availability, also at partner level.’

Covington & Burling LLP

Led by the renowned Adem Koyuncu , Covington & Burling LLP has established a firm foothold in the German market since opening its Frankfurt office in 2018. With a focus on life sciences, Koyuncu and his ever-growing team advise on pharmaceutical and medical device law, with support offered to both companies as well as associations. The team works as a standalone practice, but also cooperates synergetically with the firm's other practises. The combined expertise is of particular importance at the intersections with transactions, compliance as well as IT and data protection law. The life sciences team also benefits from increasing capabilities in the antitrust and dispute resolution practices. Thanks to the well-established Brussels office, the firm is experienced in matters under European law, such as the pharmaceutical sector.

Practice head(s):

Adem Koyuncu


‘The Covington practice is characterized by very well-founded knowledge and a high affinity for entrepreneurial thinking. This gives you fast and focused legal advice. Every minute of advice is worth the price.’

‘Adem Koyuncu is not only a lawyer but also a doctor and has worked in industry. He knows the perspectives that also move in-house lawyers. He is also very sharp and quick, while at the same time having a good sense of humor and nerves of steel. Very pleasant to work with.’

Key clients



EFPIA – European Federation of Pharmaceutical Industries and Associations

JenaValve Technology GmbH

MedTech Europe

Capio Deutsche Klinik

Work highlights

  • Comprehensive advice to BioNTech SE on a variety of regulatory, contractual and data protection issues.
  • Cross-office advice to AstraZeneca on German data protection and regulatory issues in connection with a digital health cooperation.
  • Comprehensive advice on medical device law to the JenaValve Group with its US and UK companies on various issues of EU medical device law as well as compliance management and contract drafting issues.

D+B Rechtsanwälte Partnerschaft mbB

Specialised boutique D+B Rechtsanwälte Partnerschaft mbB focuses on statutory health insurance law. The firm has its headquarters in Berlin as well as branches in Düsseldorf and Brussels and fields several teams, such as the pharmaceuticals and pharmacy group led by Ulrich Grau and Constanze Püschel, the physician contract law team led by Martin Stellpflug and Thomas Willaschek as well as a team of hospital experts led by founding partners Thomas Bohle and Christian Reuther. Digital health, including associated data protection issues, constitutes a growth area in addition to the team’s expertise in criminal law and competition law matters. The firm routinely offers independent regulatory advice, but has also expanded regulatory support in the transactional space, both in cooperation with M&A boutiques and larger law firms at national and international level. Maximilian Warntjen (medical criminal law); Jan Moeck (physician contract law and psychotherapist legislation, health care professions) and Christian Pinnow (physician contract law and psychotherapist legislation, digital health, medical care centers) are also among the key contacts.

Key clients

Bundesverband der deutschen Urologen e.V. (BvDU)

Astra Zeneca

DMS Medical Supply Germany GmbH (Kry)

Helios Health GmbH


RECURA Kliniken SE, Beelitz-Heilstätten

Universitätsklinikum Leipzig


Lebenshilfe Berlin

NORDMED Healthcare GmbH

Ambulanzzentrum des UKE GmbH

amedes Medizinische Dienstleistungen GmbH

Augenklinik Stadthagen GmbH

Shop Apotheke

ALK Abelo

Work highlights

  • Comprehensive regulatory advice to DMS Medical Supply Germany GmbH (Kry) on market entry and cooperation with market participants and payers.  
  • Advising a global biopharmaceutical company in the area of tenders and patent law; Obtaining a decision before the public procurement senate of the Düsseldorf Higher Regional Court, according to which health insurance companies must already take application patents of pharmaceutical companies into account when designing the tender.
  • Comprehensive regulatory advice to an international laboratory company, including on the framework conditions of the private and statutory health insurance market, establishment of MVZ, Covid-19 test centers, medical device law.

Gleiss Lutz

Gleiss Lutz is a renowned practice for advising health insurance companies on social security law. Growth areas are digitisation and compliance issues, especially medical device and pharmaceutical companies regularly instruct the team on the latter. Digitisation matters, including data protection, were increasingly at the forefront of the support offered to e-health providers and investors. In 2020, the transactional team was highly active in the clinical space, not least due to the takeover of several big clients from other law firms. Other advisory strengths are public procurement law, mass litigation and patent law. Covid-19 played a role in advising lateral flow test developers and manufacturers of active ingredients. Reimar Buchner in Stuttgart and Martin Viciano Gofferje in Berlin head the practice. Counsel Jan-Peter Spiegel moved to the legal department of the National Association of Statutory Health Insurance Physicians in January 2021.


‘Trustworthy partners.’

‘High level of competence and knowledge, quick feedback and high reliability.’

‘Excellent legal advice and legal representation, especially across legal areas, quick processing and excellent knowledge of the healthcare sector.’

‘The people are all characterized by competent and efficient advice and legal representation: Reimar Buchner, Enno Burk.’

‘Immediate responsiveness with a high level of competence: Marco König.’

‘Well coordinated, if necessary additional expertise is added, broadly based.’

‘Gleiss Lutz is superb. They are dyed in the wool of industry and their advisory approach is always pragmatic and solution-oriented, especially when it comes to complex M&A transactions in an incredibly complex regulatory environment.’

‘The team is responsive, efficient and thorough.’

‘Very honest, accurate and responsive.’

‘Highest professional expertise, good accessibility.’

‘Marco König is a highly qualified lawyer who quickly recognizes – often complex – problems and finds very good solutions.’

Key clients

AOKen (Bundesverband, Landesverbände)


Carl Zeiss Meditec

Paracelsus Kliniken

Klinikum Lippe


Brainlab AG


Karl Storz SE & Co. KG

DiosCURE Therapeutics

Zur Rose Group AG

Work highlights

  • Comprehensive and cross-legal advice to the start-up company DiosCURE Therapeutics on founding, setting up the corporate structures and in the context of seed financing.
  • Advice and representation of the substitute health insurance funds under the leadership of the vdek regarding the nationwide reclaim of excessive VAT invoices (19% instead of 7%) by all non-profit hospital operators for the delivery of finished medicinal products in several 100 cases, of which more than 250 lawsuits are pending throughout Germany.
  • Ongoing advice to the Paracelsus clinics on the restructuring of the group, the acquisition of new hospitals and the sale of existing facilities, in particular the sale of the Paracelsus clinic in Osnabrück to the Niels-Stensen clinics and the acquisition of the acute geriatric unit at the Marien Hospital in Nassau.  

Hengeler Mueller

Hengeler Mueller combines both transactional and regulatory expertise. In 2020, private equity houses in particular were advised on small-scale transactions in the clinics and hospitals segment, as well as clients from specialised sectors such as medical device manufacturers. Digitisation was at the forefront of the regulatory and data protection advice to health platforms, for example on clinical studies. The team also advised on Brexit-related regulatory issues. Among the key contacts are Wolfgang Spoerr (Berlin) Dirk Uwer (Düsseldorf) and Counsel Susanne Koch (Düsseldorf), who offer industry-specific advice on public commercial law and are well versed in transactional and contentious matters. Alexander Nolte (Düsseldorf) is a key contact for M&A.


‘Outstanding expertise, results validated and processed very thoroughly.’

Latham & Watkins LLP

Latham & Watkins LLP remains one of the leading transaction teams in Germany. Underpinned by the regulatory expertise of practice heads Henning Schneider and Christoph Engeler, the team advises on traditional M&A matters as well as transactions in the private equity space. The group regularly assists with some of the largest deals in Germany. Matters pertaining to the healthcare and life sciences sector are handled by the firm, such as hospital and nursing home takeovers as well as pharmaceutical transactions, strategic licensing agreements and compliance mandates, including related data protection aspects, with further expertise in procurement, litigation, financing, tax and employment law also covered; IP know-how complements the transactional advice. The German team regularly cooperates with the US colleagues and is one of the core teams of the healthcare and life sciences initiative in Europe, which was jointly launched with the offices in Paris and London.


Excellent legal and economic understanding – extremely strong network and transaction experience – excellent problem-solving skills and creative approaches – goal-oriented.

Henning Schneider is a unique advisor with excellent industry and legal understanding; creative in dealing with highly complex situations; very solution-oriented; best consultant in the market.

Key clients






Chequers Capital


IK Partners

I Square Capital

KMK Kinderzimmer Gruppe

Landkreis Goslar

Malteser Orden Deutschland

Novo Holdings


Quadriga Capital

Rhön Klinikum

SHL Telemedizin

Siemens Healthineers


McDermott Will & Emery Rechtsanwälte Steuerberater LLP

McDermott Will & Emery Rechtsanwälte Steuerberater LLP ‘s team experienced significant change in 2021: Rüdiger Herrmann as well as Jochen Eimer moved to Squire Patton Boggs in January and counsel Alicia Hong left the practice for BioNTech, whereas counsel Karolin Hiller joined Hogan Lovells International LLP in March. In Frankfurt, counsel Monika Emilia Richter is now the key contact responsible for the close cooperation of both offices, with increasing support from counsel Deniz Tschammler. Practice head Stephan Rau (Munich) and Nadine Hartung (Munich) successfully expanded the client roster with several new clients from both the healthcare and life sciences sectors. Clients from the pharmaceutical, medical device and biotechnology areas are also supported with regulatory and data protection expertise. Another strength of the firm is its international network. The German group’s cooperation with offices in France, Great Britain and the US is increasing due to demand from pharmaceutical, medical device and online health service providers.

Practice head(s):

Stephan Rau


‘Stephan Rau and Nadine Hartung perfectly implemented the combined advice on M&A and medical law.’

‘Stephan Rau: Good overview of health law and M&A, deep understanding of the commercial background of transactions. Nadine Hartung: Excellent M&A lawyer. The contracts read very well and do not unnecessarily frighten the other side. Very solid and comprehensive advice – and always cleanly draws the cross-connections to medical law. Sylvia Petereit-Kemter: Very solid advice on medical law, always solution-oriented.’

‘We receive excellent support from McDermott. We have a team on our side that knows our market and competitive environment very well and is familiar with all types. McDermott’s industry knowledge and experience clearly sets them apart from competitors I have worked with in the past.’

‘Deniz Tschammler and Jana Grieb are characterized by excellent expertise in clinical trial law and medical device law. The advice is excellent and well-founded. Deniz Tschammler gets to the heart of difficult negotiations quickly and has practical, implementable solutions. He is flexible in terms of time, very committed and always easy to reach.’

‘The team around Monika Richter and Deniz Tschammler offers an exceptional combination of industry expertise in the healthcare sector and deal experience.’

‘With his result-oriented manner, Deniz Tschammler delivers the desired results in an efficient manner and selflessly and skilfully ignores unnecessary tips from inferior negotiating partners.’

‘The McDermott team has a pragmatic, business-centric approach to consulting, which is important to us. They don’t sell you more than necessary either, which we appreciate.’

‘Very pragmatic, agile and practical approach with at the same time outstanding quality in terms of legal advice, a very well-founded overview of the market and enormous commitment when it comes to supporting the client. Great sense of the ‘right’ tone to effectively move forward in negotiations.’

Outstanding quality of legal advice and in terms of negotiation/super pragmatic/creative and agile solutions/absolutely reliable/very pleasant cooperation. You feel well looked after all around. Extremely in-depth knowledge of the pharmaceutical industry and the rare ability to involve and ‘pick up’ the internal specialist departments.’

‘The team works in an extremely professional and goal- and client-oriented manner, is extremely thorough and can be contacted at any time. The short reaction times are particularly welcome in negotiations with international partners from different time zones and are hardly provided in a comparable way by other law firms.’

‘Deniz Tschammler is very familiar with the topics of MedTech companies, is technically well versed and has excellent knowledge of the international legal situation in the health sector. In the event of problems, he always has a suitable strategy ready for a solution – always in the interests of his clients – which he then implements operationally in a highly professional manner. Extremely proactive, committed, competent and very friendly to deal with.’

‘Monika Richter: forward-thinking, careful, razor-sharp when it comes to implementing clients’ interests.’

Key clients

Ajax Health

Charité und Labor Berlin

Softhale N.V.

Dialyse Service

Galeria Karstadt Kaufhof






Work highlights

  • Representing the shareholders and Softhale NV in negotiations with various bidders and the sale of the company to Sino Biopharm for $110 million plus unlimited milestones.
  • Advising Merck KgaA in negotiations with Neuroloop, Aesculap and B. Braun on a joint cooperation in the area of development and commercialization of a novel, implantable medical device for the treatment of neurological diseases.  
  • Advising GREENPEAK Partners Advisory GmbH on a majority stake in the St. Vinzenz-Klinik Pfronten im Allgäu GmbH for the ACADEMIA Group.

NOVACOS Rechtsanwälte

Düsseldorf boutique NOVACOS Rechtsanwälte offers longstanding regulatory expertise in the healthcare, biotechnology and chemical sectors. The five founding partners Maria Heil, Marc Oeben, Christian Hübner, Alexander Natz and Christian Stallberg have oriented the firm towards the international market. In addition to numerous healthcare providers as well as companies from the pharmaceutical, food and medical device sectors, the team also advises investors, banks and research institutions (the latter in particular on clinical trials) and provide regulatory expertise for law firms without healthcare specialists, especially in M&A transactions. The group advises on market access and reimbursement issues, product safety and compliance matters as well as industry-specific contract law. Interface expertise in data protection and public procurement law complements the service spectrum as well as experience in advising associations, evident in Natz’ role as managing director of the European pharmaceutical association Eucope.


‘Pragmatic. Technically good.’

‘Maria Heil and Marc Oeben are both great.’

‘Fast, flexible, highly specialized.’

‘Very diverse team. Very high level of expertise in pharmaceutical law and SGB V.’

‘Christian Stallberg: Very high level of expertise in pharmaceutical and social law. In addition, extensive knowledge of antitrust law. Outstanding expertise.’

‘Highly competent, reliable, able to listen, respond to the concerns of the client, can also convey the topics in an understandable way to non-lawyers, always solution-oriented, creative and innovative in thinking.’

‘Unique experience in healthcare.’

‘Here sympathy meets competence.’

‘Christian Stallberg has in-depth specialist knowledge and, despite the complexity of the subject, is able to present it simply and to the point. Good understanding of the industry.’

Maria Heil has a wide range of expertise in the health sector, ranging from data protection to social law. She is available and committed at all times.

‘Regardless of whether it is a large transaction or an isolated legal issue, Novacos is always at our side with outstanding expertise and a great deal of commitment.’

‘The collaboration with Christian Stallberg, Christian Hübner, Marc Oeben and Maria Heil is both incredibly pleasant on a personal level and always at the highest level in terms of content. Advice at the level of a large law firm on fair terms.’

‘Maria Heil is simply an expert.’

‘Excellent combination of outstanding legal-analytical skills and industry knowledge.’

‘Christian Stallberg: Outstanding head in the area of SGB V – even really difficult individual questions can be answered reliably using well-founded legal methods. Mr. Stallberg also appreciates the close connection to the business; he is a well-respected and fully integrated comrade-in-arms, especially in all areas of AMNOG.’

‘Deep legal expertise in almost all relevant areas of the healthcare business.’

‘Christian Hübner is a very experienced and pragmatic lawyer in the area of drug advertising and competition law.’

‘Clear focus on Healthcare/Regulatory. Very good industry knowledge and involvement in numerous transactions in this area.’

‘Marc Oeben: Very good, fast, efficient and pragmatic.’

‘Due to the very high technical competence in the area of the healthcare sector, we are always our first contact for questions from this area, also because of the pragmatic solution proposals that we can easily implement (e.g. in the area of healthcare compliance).’

‘It is a young and dynamic team that is not only characterized by competence, accessibility and flexibility, but also has an ‘open mindset’.’

‘Christian Hübner is an excellent sparring partner when it comes to discussing possible legal avenues for an innovative project. He also has excellent knowledge of competition law.’

‘Alexander Natz: Outstanding strategic skills, social and political networking.’

‘Christian Hübner has an exceptionally good understanding of the regulatory framework and its impact on the business.’

‘The team impresses with its comprehensive professional competence in all life sciences-related legal issues.’

‘Maria Heil, Christian Hübner, Marc Oeben and Christian Stallberg are extremely pleasant to work with, creative and innovative in their legal solutions and, thanks to their many years of dealing with relevant issues, also have a profound understanding of specific industry issues.’

‘Das Team überzeugt durch die umfassende fachliche Kompetenz in allen auf Life Sciences-bezogenen Rechtsfragen.’

‘Maria Heil, Christian Hübner, Marc Oeben und Christian Stallberg sind äußerst angenehm in der Zusammenarbeit, kreativ und innovativ in ihren juristischen Lösungsansätzen und verfügen durch ihre langjährige Befassung mit einschlägigen Themen auch über ein profundes Verständnis spezifischer Branchenthemen.’

Key clients

Roche Pharma AG

Dr. Willmar Schwabe GmbH & Co. KG

Inspire Medical Systems Inc.



Eckert & Ziegler

Insmed Inc.

Novartis Gene Therapies Inc.

Orchard Therapeutics

Pharming Group N.V.

Work highlights

  • Advising and representing manufacturer associations in ongoing arbitration proceedings against the National Association of Statutory Health Insurance Funds to determine the framework agreement for apps on prescription (DiGA).
  • Advising Novartis Gene Therapeutics on drafting and negotiating contracts with health insurance companies and various hospitals on Zolgensma.
  • Advising Oakley Capital on the acquisition of WindStar Medical GmbH (one of the leading OTC consumer healthcare companies in Germany).

Sträter Rechtsanwälte

Practice head(s):

Burkhard Sträter

Other key lawyers:

Markus Ambrosius

Taylor Wessing

Taylor Wessing covers both the healthcare and life sciences sectors. In 2020, the firm expanded its expertise in digital health, including IT and data protection advice, regulatory advice on pharmaceutical law, pharmaceutical advertising law and advising clients from the biotechnology sector. Corona-related instructions have also led to an increased demand in the advice on medical device law, distribution agreement matters as well as patent law. In the hospital sector, the team handles matters pertaining to the Hospital Future Act, including related procurement and data protection aspects. The  firm’s transaction practice, in frequent cooperation with the regulatory specialists, saw further growth in matters pertaining to medical care centers, inpatient facilities and in the care property sector, while the group also advised on transactions in the pharmaceutical and life sciences arena, including venture capital. The group’s international presence and its established relationships with US firms continue to generate numerous cross-border instructions. Cornelius Weitbrecht retired in December 2020. In Munich, patent law specialist Anja Lunze and Daniel Tietjen, who specialises in competition and trade mark law, were promoted to equity partners in May 2021, while Andrea Sautter, who specialises in regulatory advice and IP, was promoted to salary partner in December 2020. In Hamburg, M&A and venture capital specialist Niclas von Woedtke, previously at the Otto Group, joined the team as salary partner. Manja Epping in Munich and Michael Stein in Frankfurt jointly head the practice. The ‘Next Norm Legal’ initiative, launched in 2020, deals with the legal and social changes caused by the corona pandemic, especially those in the context of digitisation. The firm’s ‘Digital Legal Academy’ is dedicated to matters at the interface between digitisation and law.

Practice head(s):

Manja Epping; Michael Stein


‘Very reliable and accessible, high quality throughout the team, consistent and with an eye on price transparency for the client, with regular cost updates.’

‘Cover very specialized areas with deep market knowledge, especially IT, regulatory and data protection.’

Strong team with interdisciplinary competence and a convincing full-service approach. All specialist areas such as personnel law, real estate, data protection, regulatory matters, etc. work together excellently under the umbrella of the healthcare industry. In particular, the specific industry know-how of the individual specialist areas is convincing in relation to healthcare issues.’

Oliver Kirschner, Michael Stein and Oliver Klöck form a strong team for private equity clients with a focus on healthcare transactions. Their cooperation with and coordination of the various specialist areas is convincing in the long term.’

Key clients

aap Implantate




Blackrock Microsystems


Dana Farber Cancer Institute

DRK Blutspendedienst

Fine Hygienic Holding (Dubai)

FSA e.V. (Verband Süddeutscher Apotheker)


Illumina Cambridge




W.L. Gore

Work highlights

  • Advising amedes on the acquisition of several medical practices, MVZ and laboratories.
  • Advice to AviaRent on several transactions involving care properties and day-care centers.
  • Many years of advice to Biotest on regulatory issues and increasingly on data protection and antitrust law.


The core topics of Dentons‘ healthcare and life sciences practice are corporate and M&A matters as well as regulatory advice. Clients can also draw on the expertise of other practices such as public procurement law, employment law and insolvency law. Christof Kautzsch specialises in transactions in the hospital sector, including restructuring and privatisations, and jointly heads the practice with Peter Homberg, head of the firm’s German life sciences and European cannabis sector groups, as well as medical law specialist Ilka Mehdorn. She is also one of the leaders of the European life sciences regulatory group and co-head of the public sector practice in Germany. Her areas of expertise include contracts with regulatory aspects, social data protection issues, arbitration and court proceedings under social law and compliance. Thomas Strassner (Munich) and his team cover the private equity sector and in particular the venture and growth capital practice. Ann-Kristin Cahnbley (Düsseldorf) covers the white collar crime and compliance space, while Jörg Karenfort is a key contact for antitrust law. Utz Andelewski moved to Heuking Kühn Lüer Wojtek at the beginning of 2021.

Key clients

AMEOS Gruppe

BG Kliniken Holding; BG Kliniken Tübingen und Reutlingen gGmbH


EU Malaria Fund

Fresenius Medical Care AG & Co. KGaA

Greenfield Global Opportunities Fund Limited Partnership

HÄVG Hausärztliche Vertragsgemeinschaft

Immunic AG

Investitionsbank Berlin (IBB)

Johanniter GmbH

Kaia Health Software

KKR-Portfoliounternehmen WebMD

Nordwest Dental GmbH & Co KG

numares AG

Prospitalia GmbH

Roche Diagnostics GmbH

Velvio GmbH

Yonsung Group

Work highlights

  • Ongoing advice to an internationally active Swiss pharmaceutical company on a large number of distribution contracts, model contracts of all kinds and on compliance issues.
  • Advising Greenfield Global Opportunities Fund Limited Partnership on a significant investment in CANSATIVA, a German medical cannabis company and logistics partner of the Cannabis Agency (BfArM).
  • Advising the Berlin-based EU Malaria Fund on risk financing for the biotech company Sanaria (venture loan for the development of two malaria vaccines, a malaria therapeutic and an oral Covid-19 vaccine).


Dierks+Company offers combined support with legal issues, project management as well as IT expertise in the healthcare sector. Based in Berlin and led by the renowned Christian Dierks, the group advises on regulatory issues at the interface with digitisation. The team regularly offers support with the development of new medical devices and digital health services, with further advisory topics including benefit assessments and reimbursement issues, clinical trials and conformity assessments. Pharma specialist Karsten Engelke is one of the key contacts. Internationally, the practice is part of the co-founded BioLaw Europe network, among other things, and is well positioned for cross-border mandates. Katrin Helle, previously at White & Case LLP, specialises in matters pertaining to medical devices, pharma and healthcare and joined the team in November 2020, followed by senior partner Ulrike Knirsch, who joined from Roche Pharma; his expertise in management and consulting complements the advisory offering.

Practice head(s):

Christian Dierks


‘Agile and dynamic way of working at the highest level, up to date and a little bit beyond. Specialists from all relevant areas such as MedTech, reimbursement, social law, data protection, digital & innovation topics united in one boutique.’

‘Christian Dierks: Unique expertise combined with the best overview of current issues and endeavors in political Berlin.’

‘Very good, case-related composition of the teams. High flexibility. Very good and wide-ranging know-how (legal and technical). Good coordination among each other.’

‘Great industry expertise, very innovative solutions, interdisciplinary team of lawyers and consultants.’

‘Karsten Engelke: Always available, very innovative solutions.’

‘Comprehensive familiarization with the client’s problems. High personal commitment of the partner. Employees who have been called in show careful detailed processing of the questions and are guided by the partner in regular coordination meetings.’

‘The law firm has had a good internal dynamic for several years and has a comprehensive view of the multilateral interests of the various stakeholders in the healthcare sector and can therefore provide orientation very close to the realistic feasibility and deliver successful strategies in the design of legal processes.’

‘The team has the advantage of not only excelling with legal considerations, but also providing consulting for consecutive implementation. Especially in the rapidly changing legal area of digital health, the law firm is a proactive contributor to the updating of regulations that are no longer up-to-date or in need of new regulations.’

‘Christian Dierks is undoubtedly a highly agile, extremely well-balanced and intelligent lawyer who, far more than most of his colleagues, has a feeling for the entire balance of power and choreographies of legal constellations in the German and European healthcare system. He is exceptionally well connected and has excellent international contacts. He is regularly consulted by all sides (Federal Ministries, doctors, pharmaceuticals and the public sector) and thus keeps a multifaceted view that sharpens legal assessments extraordinarily.’

‘Very strong focus on innovation in the healthcare sector.’

‘Christian Dierks is a very clever person. Karsten Engelke is outstanding.’

‘Professional excellence combined with industry knowledge that is otherwise hard to find and an interdisciplinary range of advice that focuses on the added value for patient care makes working with Dierks+Company unique.’

‘High professional competence of the contact person.’

‘Remarkable professional depth also in peripheral areas. Very competent and reliable in processing. Short reaction times and timely reliability in close dialogue.’

‘The founding partner has many years of experience in almost all areas of medical law, resulting in a wide range of mandates and networks.’

‘Karsten Engelke: Excellent knowledge of the pharmaceuticals sector (esp. AMNOG), in addition to the legal aspects, also a good understanding of the medical/technical background.’

‘Dierks+Company’s practice is unique in that it represents a rare combination of excellent technical science, creativity and social competence.’

‘Christian Dierks differs from many of his colleagues in that he first really listens before coming up with analyzes or solutions.’

Key clients

Abaton GmbH

Aino UG

Alexion Pharma Germany GmbH

Alnylam Pharmaceuticals


Apotheke im Elisenpalais

Atriva Therapeutics

Becton, Dickinson and Company

Belle Époque Gruppe

Bencard Allergie GmbH

Berlin Institute of Health





Bundesministerium für Gesundheit (BMG)

Bundesverband der Pharmazeutischen Industrie e.v. (BPI)

Charité Research Organisation


CompuGroup Medical SE & Co. KGaA (auch CGM)

Cord Blood Center

Das Lab GmbH


Deutsche Dermatologische Gesellschaft





European Federation of Pharmaceutical Industries and Associations (EFPIA)

Expert Med

Flatiron Health Inc

Föckersperger Ventures GmbH

Galapagos N.V.

gematik GmbH

Gesundes Kinzigtal GmbH


Hexal AG





Labor Berlin


LEO Pharma

Lohmann & Rauscher GmbH & Co. KG


Media Chain Products



neoplas med GmbH

NOVENTI HealthCare

Ovesco Endoscopy

Pfizer Pharma GmbH

Pluristem Therapeutics Inc.


QD Laser


Retrobrain R&D

Samsung Electronics GmbH

Santen Pharmaceutical



Stemform A/S

Systasy Biosciene GmbH

True Skin

Universität Bielefeld

Universitätsklinikum Essen

Universitätsklinikum Tübingen

Universitätsmedizin Greifswald

Verband Forschender Arzneimittelhersteller e.V. (VFA)

Vifor Pharma Deutschland GmbH

Vision Zero

Vivira Health Lab GmbH


Zambon GmbH

Zur Rose Group

Work highlights

  • Advising Alexion Pharma GmbH on all drug law issues, in particular on the early benefit assessment and subsequent price negotiations with the Central Association of Statutory Health Insurance for the three most important products, including legal support for the dossier preparation, strategic preparation of the price negotiations and formulation of the contract for the reimbursement amount.
  • Preparation of several expert opinions for the Federal Ministry of Health on the expansion of the right to benefits in statutory health insurance and data processing in an international context, on the basis of which the law on digital health applications (diGA) and the new regulation on the lead supervisory authority for cross-state research projects were drafted.  
  • Advising Flatiron on the creation of a data protection concept and a data protection impact assessment, with which patient-related health data from the hospitals are deeply curated and transferred to a database that universities, institutions and companies can use to conduct scientific research at the highest level.


Fieldfisher convinces with its internationally oriented healthcare, pharmaceuticals and life sciences group in Germany, France, Belgium and Great Britain. The German partner trio consists of Cord Willhöft (market access, reimbursement, compliance for medical device and pharmaceutical manufacturers), Stefanie Greifeneder (commercial IP), both in Munich, and Michael Adam in Hamburg, who specialises in corporate and antitrust law in the life sciences sector.


The Fieldfisher team is always at our side with pragmatic advice. Fieldfisher understands how to give legal advice in the form and language that the client desires. Cord Willhöft is pragmatic, experienced and proactive.

‘Very experienced team, especially in the field of medical device law, both in terms of regulation and with regard to market access. Cord Willhöft has an excellent understanding of the needs of his clients, be they individual companies or associations.’

Key clients

Advanced Bionics GmbH und Advanced Bionics AG

Amisar Munich Biohealth GmbH

Asahi Kasei Medical Co Ltd

Axonics Ltd.

Gala Therapeutics

Intersect ENT Inc

Kawasaki Robotics


Procept BioRobotics

Pulmonx Sarl und Pulmonx Co.

ResMed GmbH & Co KG

Retina Implant AG

Saluda Medical

ZOLL CMS GmbH und ZOLL Medical Corporation

Olympus/KeyMed Gruppe

Friedrich Graf von Westphalen & Partner

Friedrich Graf von Westphalen & Partner in Freiburg has longstanding experience in advising pharmaceutical, medical device and biotechnology companies. Numerous medium-sized and small companies are among the client portfolio, but the team, led by practice heads Barbara Mayer and Hendrik Thies also advises international corporations. The Frankfurt office primarily focuses on employment law matters, where Sabine Schröter is a main contact, as well as the transactional space, which expanded with Annette Bödeker from the now closed office of Arnold & Porter Kaye Scholer. Other growth areas in 2020 were synergies between commercial and corporate law as well as IP and regulatory advice, especially in the medical device sector. The team also offers support with M&A matters in the healthcare sector and has expanded its mandate portfolio. Other key topics are pharmaceutical advertising law, compliance, product liability and pharmacy law. Morton Douglas (Freiburg) specialises in the latter.

Practice head(s):

Barbara Mayer; Hendrik Thies


‘The law firm Friedrich Graf von Westphalen is well versed in the field of healthcare, which is true of very few law firms. The lawyers have proven expertise in the areas of labor law, contract law, compliance and medical law. Always available at short notice and unconventional in the approach to the solution requirements.’

‘Sabine Schröter is a professional lawyer in the ‘jungle’ of German employment law, who is very familiar with the current legislation and knows the hurdles and obstacles for employers and thus develops future-oriented contracts, guidelines or agreements. Furthermore, she is a proven coach and moderator as a link between employee representatives and employers.’

Accessibility and feedback speeds are absolutely top. Content is always at a high level. Reliability and very broad and specific knowledge.’

Key clients

Apothekerkammer Nordrhein

Cranach Pharma GmbH

Dt. Versandapotheke Fliegende Pillen


Essilor GmbH

Getinge Deutschland GmbH

Getinge AB, Schweden

Lenus GmbH

Neuroloop GmbH

Paracelsus Kliniken Deutschland GmbH & Co. KGaA

Pulsion Medical Systems S E

Schölly fiberoptic GmbH

Tillotts Pharma AG

Work highlights

  • Ongoing sales law advice to a medical device manufacturer.
  • Advising a medical technology network on model contracts for authorized dealers under the new Medical Devices Directive.  
  • Ongoing advice to the North Rhine Chamber of Pharmacists on numerous landmark proceedings before German and European courts.

King & Spalding LLP

King & Spalding LLP focuses on regulatory advice in the life sciences space. Practice head Ulf Grundmann and senior associate Elisabeth Kohoutek cover both the interface between pharmaceutical and food law and the regulatory framework for pharmaceuticals and medical devices. In 2020, the health claims regulation, the counterfeit drug directive, including advice on the corresponding trade mark law issues and the representation of Novartis in a market-known ECJ procedure, as well as the regulatory support of transactions were among the practice's core areas. Growth was seen in particular in data protection issues, also in the context of digital health, artificial intelligence and ESG. The German practice regularly cooperates with the US colleagues in the Washington DC office.

Practice head(s):

Ulf Grundmann

Other key lawyers:

Elisabeth Kohoutek


‘Very in-depth knowledge and excellent understanding of client business, combined with creativity and the ability to approach problems from a completely different perspective.’

Key clients

Novartis Pharma AG

ratiopharm GmbH

GlaxoSmithKline Consumer Healthcare GmbH & Co. KG (GSK Consumer Healthcare)

Famous Brands GmbH

Angelini Pharma Deutschland

Pfizer Consumer Healthcare

Teva GmbH Deutschland GmbH

Teva Pharmaceuticals B.V.

Dr. Willmar Schwabe GmbH & Co.KG

Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG (DHU)

Roche Diagnostics GmbH

Amy’s Kitchen

VSM Geneesmiddelen B.V.

Chemische Fabrik Kreussler Co. GmbH

Daizu GmbH

Dr. Kade Pharmazeutische Fabrik GmbH

Diagnostic Green

SGF International e.V.

Eckes-Granini Group

AGNovos Healthcare

Truw Arzneimittel GmbH

biomo-vital GmbH

Gamers Only GmbH

Work highlights

  • Representing Novartis Pharma AG as the original manufacturer in the first referral procedure before the ECJ on the counterfeit medicines directive.
  • Representation of ratiopharm GmbH in proceedings against the parallel import of medicines from ratiopharm to Germany, in particular against the background of the change in medicines law due to the counterfeit medicines directive.  
  • Advice to GSK Consumer Healthcare in connection with OTC products in competition law disputes and advice in connection with drug, food and medical device law.

Meisterernst Rechtsanwälte

Meisterernst Rechtsanwälte stands out with dually focused expertise in pharmaceutical and food law. The team, led by practice head Christian Tillmanns, is highly specialised and experienced in contentious matters relating to the advertising of medicinal products, supporting market-shaping fundamental proceedings, issues relating to the differentiation of pharmaceuticals, food and cosmetics and a broad portfolio of compliance matters such as professional law issues and inpatient care programs. The expertise in medical device law as well as the growth areas artificial intelligence and 3D printing are further key topics.

Practice head(s):

Christian Tillmanns

Other key lawyers:

Sylvia Braun


‘The team is well organized and delivers reliably with great expertise, especially in competition law. We were impressed by the extreme commitment and proactive initiatives in relation to a complex counterfeit drug case.’

‘Christian Tillmanns is a very experienced and reliable consultant. He is characterized by his willingness to familiarize himself deeply with the processes and their technical fundamentals and to act consistently and assertively.’

Sylvia Braun is a dedicated, thoughtful and experienced competition advisor.’

‘A well integrated team.’

‘Christian Tillmanns delivers excellent work.’

‘Law firm with very competent and friendly lawyers, relatively broad spectrum. In addition, always friendly office team.’

‘Christian Tillmanns and Sylvia Braun: Both very competent, fast, reliable, respond promptly to queries/callback requests. Inform comprehensively.’

‘A highly motivated team on an equal footing, ie our concerns are taken seriously, discussed in depth and solutions discussed together so that they can be implemented practically and pragmatically.’

‘The lawyers with whom we are in direct contact are very competent, have the relevant specialist knowledge and can also convey this in an understandable way (ie no legal lingo is spoken). The employees of the law firm are all very courteous, helpful and maintain a very good, friendly relationship with us as clients.’

‘We work very successfully with the law firm Meisterernst, especially in competition, medical device and pharmaceutical law.’

‘Christian Tillmanns and Sylvia Braun represented us extremely competently and successfully in and out of court. In addition to the advertising law and procedural competence and experience of the team around Christian Tillmanns, the breadth of the consulting practice (contractual advice, regulatory and social law matters, etc.) should also be emphasized.’

The advice is characterized in particular by the great experience, high level of expertise, great pragmatism and target-orientation. Particularly noteworthy is the tactical skill and the great competence and experience in competitive processes, for us the team led by Christian Tillmanns has won some very important processes. The client focus and pragmatism with high professional quality deserve particular praise.

‘The team is experienced in pharmaceutical and medical device law as well as in food law and has good knowledge of the industry.’

Key clients

Alnylam Germany GmbH / Alnylam Switzerland GmbH

LifeScan Deutschland GmbH

Miracor Medical S.A.

Queisser Pharma GmbH & Co. KG

Salus Haus Otto Greither Nachfolge GmbH & Co. KG

Work highlights

  • Assisted Alnylam Germany GmbH/Alnylam Switzerland GmbH in preparing for the market entry of new products for the US-headquartered biopharmaceutical company Alnylam, which is a leader in the development of drugs based on RNA interference (RNAi).
  • Many years of advice to Queisser Pharma GmbH & Co. KG with a focus on herbal OTC and dietary supplements, in particular on regulatory and advertising law issues, most recently on issues of adapting drug names to existing brands and new product lines.
  • Representing Salus Haus in court on a wide variety of fundamental issues relating to the admissibility of advertising and packaging design, including medicinal and herbal teas, most recently on the admissibility of advertising medicinal products with organic labels and the compatibility of German pharmaceutical law with European law in this regard.

Möhrle Happ Luther

Möhrle Happ Luther fields Henning Anders, who is one of the most renowned AMNOG experts in Germany. Other key areas are pharmaceutical advertising law, here Julia Luther and Joachim Jung are particularly active, as well as compliance and contract law advice. The latter includes, among others, research and development as well as distribution contracts. In addition to its legal team, the Hamburg firm also offers its own auditing and tax services.


‘A well-established team around Henning Anders.’

‘Henning Anders has extensive experience in the pharmaceutical industry. This makes him an excellent partner for legal advice, even on complicated, unusual issues. His commitment and understanding of the problem are above average. In addition, he has developed into THE EXPERT for reimbursement issues, GBA and in the early benefit assessment.’

‘Very professional law firm in the field of life sciences, in particular extensive experience in the areas of market access and competition law/medicine advertising law.’

‘Julia Luther: Competent lawyer in the field of pharmaceutical law including market access, also in strategic issues. She also has particular expertise in intellectual property law and procedural law.

‘High professional competence. High industry knowledge. Very good accessibility. Low fluctuation among the lawyers, so that many years of experience and company knowledge can be built up.’

‘Julia Luther is a very dedicated lawyer who always acts in a friendly and practical manner. She has very well-founded industry-specific knowledge and brings with her a great medical understanding, which is essential for the successful handling of competition law procedures in the field of medicinal product advertising. She is also very focused, works very quickly and is solution-oriented. Briefs are concise and crisp, of reasonable length.’

Key clients

Almirall Hermal GmbH

Amgen GmbH

AstraZeneca GmbH

Pfizer Pharma GmbH/ Pfizer Deutschland GmbH

Work highlights

  • Advising Astra Zeneca on classic pharmaceutical law (regulatory and civil law) as well as on corporate and labor law issues.
  • Advising Amgen on drug advertising issues, comprehensively out of court and in contentious disputes.
  • Advising various pharmaceutical companies on the development of compliance concepts and processes.  

Oppenländer Rechtsanwälte

Oppenländer Rechtsanwälte‘s team is well versed in pharmacy law matters and in advising pharmaceutical and medical device companies. The group handles delimitation and distribution issues as well as competition law matters and specific aspects of pharmaceutical advertising law. Timo Kieser , Christina Koppe-Zagouras and Katharina Köbler form the practice head trio and offer legal advice as well as support with contentious proceedings. The firm’s headquarters are in Stuttgart.


‘The law firm impressed with well-founded specialist knowledge in the various niches in the industry. The partners regularly publish publications on current legal issues affecting the industry. Oppenländer are therefore always up to date and think very future-oriented. The law firm enjoys our fullest confidence.’

‘Katharina Köbler is our contact person for legal issues in the field of health and medicine. She has an excellent track record in the industry and has consistently provided us with excellent advice. She is characterized by a high degree of industry-specific professional competence, high efficiency and very pleasant and fast communication.’

Key clients

Arvato Distribution GmbH (Bertelsmann)

Deutsches Zahnärztliches Rechenzentrum und weitere Gesellschaften der Dr. Güldener-Gruppe

GlaxoSmithKline Consumer Healthcare GmbH & Co. KG

WEPA Apothekenbedarf GmbH & Co. KG

Klinikverbund Südwest GmbH


PHAGRO Bundesverband des pharmazeutischen Großhandels e.V.

Reckitt Benckiser Deutschland GmbH

MED Leaders GmbH

Dr. Falk Pharma GmbH

Beiersdorf Dermo Medical GmbH

Accord Healthcare GmbH

Work highlights

  • Comprehensive legal advice on pharmaceuticals and medicinal products to GlaxoSmithKline Consumer Healthcare GmbH & Co. KG.
  • Comprehensive advice to the Federal Association of Pharmaceutical Wholesalers on the marketability of cannabis products for medical and non-medical purposes.
  • Advising Optica on the e-prescription pilot project.

Osborne Clarke

Osborne Clarke specialises in advising pharmaceutical and biotechnology companies. Headed by Tim Reinhard in Munich, the team offers regulatory advice on pharmaceutical and medical device law and is well versed in matters at the interface between healthcare and technology, with several mandates featuring MedTech-related aspects. Matters pertaining to digital health, including digital health applications, telemedicine services and clinical studies in the digital context complement the advisory portfolio. Another successful synergy is the regular cooperation of the transactional practice with experts from the life sciences space.

Practice head(s):

Tim Reinhard

Preu Bohlig & Partner

Preu Bohlig & Partner strengthened the cooperation of its offices in Hamburg, where Daniel Hoppe advises on patent law, and Munich, where Peter von Czettritz and Alexander Meier advise on pharmaceutical, competition and cosmetics law. In addition to licensing and product liability issues, the group also advises on compliance matters. Von Czettritz is one of the most experienced experts in third-party opposition proceedings. Meier’s expertise includes orphan drugs and organic pharmaceuticals, including novel therapies. In January 2021, Tanja Strelow (pharmaceutical and food law, competition law) and Stephanie Thewes (HWG) were appointed counsel. In Hamburg, the simultaneous arrival of Jan Peter Heidenreich, previously at Harmsen Utescher, strengthened the cosmetics and pharmaceutical advertising practice.

Practice head(s):

Peter von Czettritz


‘The existing knowledge is quickly implemented in a practice-oriented and client-related manner.

Peter von Czettritz: Orders are not simply implemented, but discussed in substance and, if necessary, a measure is discouraged.’

Key clients

ALIUD Pharma GmbH ./. McNeil AB, Inc.

anvajo GmbH

Klavant GmbH

Mylan B.V. ./. Teva und Yeda

Thermofonte AG ./. Medicos

Moderna Therapeutics


Raue 's health law practice, integrated into the firm's full-service offering, mainly covers regulatory matters in the hospital sector, where practice head Wolfgang Kuhla is well versed in planning and financing issues, the drafting of cooperation agreements and physicians' contracts. In addition to hospital law expertise, Maren Bedau also handles matters pertaining to compliance and physician contract law, she regularly advises nursing care companies. Katharina Wodarz's know how includes pharmacy and pharmaceutical pricing law; she also offers regulatory support with transactions and contentious proceedings before the authorities and courts, where she regularly represents service providers. In 2020, the multidisciplinary cooperation of the firm's practices was strengthened, particularly in digitisation mandates at the interface with data protection, competition, corporate as well as employment law.

Practice head(s):

Wolfgang Kuhla


‘Whatever legal challenge arises, they always find a suitable solution, quickly and promptly. Developments in the hospital market that could have a legal impact are shown to us at an early stage and design options are presented. We feel we are in the best of hands – and have been for years.’

‘Maren Bedau: Very creative in implementing new cooperation models, high level of competence in negotiating contracts and dealing with business partners, her legal knowledge is outstanding.’

‘Jörg Adam has excellent know-how in hospital law, very experienced in litigation, we trust his legal advice.’

‘Stephanie Wiesner: Precise, fast and always with practical solutions. Very pleasant to work with.’

High level of expertise also in new legal issues. Courage to break new ground and make clear assessments.’

Maren Bedau: High level of expertise; friendly but determined negotiating behavior; Clarity in assessing risks without undue caution; Advice with foresight and real help in decision-making; pleasant representative with a good team of experts in the 2nd row and high commitment.’

Allen & Overy LLP

Allen & Overy LLP emphasised the positioning of its regulatory practice with the promotion of Eda Zhuleku to counsel in May 2021. Specialised in medical law and with expertise in the pharmaceutical and medical device sector as well as in the life sciences, Zhuleku complements the firm’s transactional and patent law capabilities. The IP practice in Düsseldorf also expanded in April 2021 with Stephan Neuhaus, formerly at Hogan Lovells International LLP; he specialises in patent law and is an experienced litigator with a focus on life sciences . The team also offers support with the digitisation of the healthcare sector, including related aspects of data protection law and transactional matters, especially in private equity. The team is lead by Alexander Veith (M&A, corporate law, capital market law) in Munich.

Practice head(s):

Alexander Veith


What was special for us was that – in our opinion – we worked with specialists who were familiar with the field of medical law and related questions and were therefore able to provide holistic answers.’

Eda Zhuleku was always at our side with advice and action and was always absolutely responsive. She gave us orientation and always gave us practical support in implementing the necessary steps.’

Key clients

GlaxoSmithKline plc


Bayer Animal Health


Apax Partners


Helios Kliniken

Sartorius AG

Work highlights

  • Advising GlaxoSmithKline plc (GSK) on a strategic cooperation with the German biotech company CureVac.
  • Advised Bayer in a significant cross-border legal dispute against Ceva Santé Animale and its subsidiaries.
  • Advising Apax Partners and its portfolio company Neuraxpharm Arzneimittel GmbH on the acquisition of the assets and rights to the prescription brand Buccolam® from Takeda Pharmaceutical Company Limited in a multinational 15-country transaction.

Ehlers, Ehlers & Partner

Ehlers, Ehlers & Partner is renowned for advising on AMNOG procedures as well as legislative procedures. The group also handles market access and compliance issues in adddition to digitisation matters such as telematics, as well as digital health products, healthcare services and data protection law. The team offers regulatory support with transactions, including in the restructuring space. The client portfolio mainly includes medical device manufacturers and pharmaceutical companies, with an ever-growing proportion of international clients, particularly from the US. Alexander Ehlers, Julian Bartholomä, who made partner in January 2021, and Christian Rybak head the practice.


‘Very competent staff.’

‘Julian Bartholomä advised us very well and quickly.’

‘Friendly, very competent team. Outstanding skills in complex issues in the field of medical law. Contact after making an appointment – also by phone – works smoothly. Transparent billing. Very good expertise in pharmacy and pharmaceutical law.’

‘Christian Rybak: Intelligent briefs, usually to the point. Christian Rybak has an excellent network.’

‘The team is well networked overall. Different core competences are used quickly when necessary in order to get a well-rounded and comprehensive overall impression of a situation.’

‘We value Alexander Ehlers for his profound medical and legal expertise, his excellent knowledge of the German and European healthcare system and his wealth of experience. Julian Bartholmä has excellent knowledge of regulatory and licensing issues for healthcare providers.’

‘Strong regulatory expertise, also on highly topical newer topics, and very good connections to relevant authorities.’

‘Julian Bartholomä is highly competent in the regulatory area for medical devices, including recent regulatory issues related to MPV. He offers efficient, business-oriented strategies for complex situations that usually lead to quick solutions.’

‘Very good knowledge and networking. Always easy to contact, pleasant to deal with, and above all very capable of regulatory, pricing and reimbursement issues in the pharmaceutical sector.’

‘Alexander Ehlers and Julian Bartholomä have very good insights into regulatory issues.’

‘Very good knowledge of the German healthcare system and excellent network of relevant representatives in key positions in healthcare policy and self-government.’

‘Excellent network in Berlin health policy, good coordination with clients.’

Key clients

Bundesministerium für Gesundheit

DigiMed Bayern

CSL Behring

Cytosorbents Europe


Deutsche Beteiligungs AG (DBAG)



Deutsche Gesellschaft für Kardiologie

Haemonetics Corporation

Horizon Therapeutics

Johannesbad Gruppe

LeMaitre Vascular, Inc.

Leo Pharma




Sanvartis GmbH


TransMedics Inc.

Work highlights

  • Advising Horizon Therapeutics with regard to market approval and market access in Germany, including extensive AMNOG proceedings for various drugs and price negotiations with the GKV-SV.
  • Advice to LeMaitre on the changeover to the Medical Devices Regulation and on special approval for various products.
  • Advice toServe on various AMNOG proceedings as well as on the regulatory framework for digital health applications.

Eversheds Sutherland

At Eversheds Sutherland, practice head Tobias Maier and Magdalena Anna Kotyrba-Hagenmaier, who made counsel in May 2021, advise healthcare companies as well as technology companies with their own healthcare departments. Regulatory advice, including on biocides and other chemicals, support with cross-border agreements in the health and life sciences sector and regulatory support with transactions generate the largest proportion of mandates. Alexander Niethammer complements the service offering with his experience in commercial matters. In addition to corona-related mandates in 2020, the team also advised on digital health, particularly health apps and telemedicine issues. Since 2020, the international sector group Health and Life Sciences is jointly led by Maier and Elizabeth Graves in Great Britain, which further underpins the practice’s international orientation.

Practice head(s):

Tobias Maier


‘Very practical approach, very good understanding of processes in companies, very high level of professional competence, precision and availability with a very good feeling for specific and practicable solutions.’

‘We mainly work with Magdalena Kotyrba, she has a very good client orientation, is very pragmatic and very good at communication.’

Key clients






Edwards Lifesciences

Owens& Minor


Aspen Pharma

Archer Daniels Midland

Vertex Pharmaceuticals

Work highlights

  • Longstanding international advice to INEOS, including on regulatory and technical requirements for biocides in Germany and on labeling requirements.
  • Advising Otsuka on a strategically important and global collaboration with the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Medical Research Institute and as further cooperation partners Evotec as well as the international pharmaceutical companies GlaxoSmithKline and Johnson & Johnson.
  • Advising Owens & Minor, the listed US pharmaceutical wholesaler, on the sale of the pharmaceutical logistics group Movianto to the French EHDH Holding Group as well as ongoing regulatory and contractual issues.

GÖRG Partnerschaft von Rechtsanwälten mbB

In addition to expertise in medical device and pharmaceutical law, pharmacy law, hospital law and issues pertaining to medical care centers, GÖRG Partnerschaft von Rechtsanwälten mbB fields industry specialists in corporate, real estate, employment and restructuring law. The team also covers IP, public procurement and antitrust law matters. Marc Schueffner in Berlin (public commercial law) and John-Patrick Bischoff in Hamburg (healthcare transactions) head the team. Katja Kuck in Cologne is the key contact for pharmaceutical and medical device manufacturers, especially on market access, manufacturing and distribution issues.

Other key lawyers:

Katja Kuck


‘Excellent interdisciplinary cooperation between corporate and medical law. Very open and communicative dealings with clients, always the highest quality.’

‘Partner availability always guaranteed. Unique combination of corporate and medical law in the person of John-Patrick Bischoff.’

‘Extremely competent and at the same time very humane team.’

Marc Schueffner offers technically outstanding, very clearly formulated opinions on medical law and public law/construction law.

Key clients

Altano Gruppe GmbH

Corius Deutschland GmbH

Endoprothesenregister Deutschland GmbH

Gemeinsamer Bundesausschuss


Insulet Corporation

Landesamt für Arbeitsschutz, Verbraucherschutz und Gesundheit (LAVG) des Landes Brandenburg

Livica GmbH

Medical Eye-Care Gemeinschaftspraxis

Mühlenkreiskliniken AöR


PubliCare GmbH

SCPI Pierval Santé

TERTIANUM Seniorenresidenzen/DPF AG

Heidelberg Pharma AG (früher Wilex AG)

HEK Hanseatische Krankenkasse

KfH Kuratorium für Dialyse und Nierentransplantation e.V.

Klinikum zum heiligen Geist Fritzlar

MorphoSys AG

RetroBrain (Memore Box)


Universitätsklinikum Frankfurt

Klinikum Westmünsterland

Work highlights

  • Advising the Oberberg Group on various project developments, in particular health law, tenancy law, employment law and various compliance and medical law issues.
  • Advice to the Brandenburg Drugs Regulatory Authority LAVG on drug law action against Lunapharm, including legal representation.
  • Advice and representation of Publicare GmbH in numerous disputes in connection with the new regulation of § 127 SGB V and the associated omission of the advertisement requirement.

GSK Stockmann

In 2020, GSK Stockmann successfully expanded its transaction and project development practice by attracting several new investors, including in the segments care properties and assisted living. The venture capital practice advises startups and investors from the healthcare, biotechnology and medical technology sectors. The firm’s traditional strength in real estate law was evident in mandates pertaining to medical centers, care centers and clinics. The interface with public law, especially in the clinical area, as well as compliance advice are further core topics. Markus Söhnchen (Frankfurt), Philip Huperz (Berlin) and of counsel Maritheres Palichleb (Frankfurt) head the practice.

Key clients

Affimed GmbH

Apogenix AG

Medicover Gruppe (Nordmed Healthcare)

Vetter Pharma-Fertigung GmbH & Co. KG

Vivantes – Netzwerk für Gesundheit GmbH

Lupin Atlantis Holdings SA

AviaRent Invest AG

coparion GmbH & Co. KG

ENDRA Life Sciences Inc.

G. Pohl-Boskamp GmbH & Co. KG

Haemonetics GmbH

Integra LifeSciences

Work highlights

  • Comprehensive advice to the Medicover Group on the acquisition of a stake in a medical care center (MVZ), in particular drafting and negotiating contracts.
  • Advising Vivantes – Netzwerk für Gesundheit GmBH on a tender procedure for the conclusion of a general contractor contract for planning and construction services for the turnkey construction of a supply and logistics center with a multi-purpose warehouse, food supply center, archive building, multi-storey car park and sprinkler tank and control center including outdoor facilities.
  • Advising the NASDAQ-listed life science group ENDRA Life Sciences on its market entry in Germany, in particular in connection with the founding of a subsidiary and including various contracts.

Luther Rechtsanwaltsgesellschaft mbH

Luther Rechtsanwaltsgesellschaft mbH expanded its regulatory practice in 2020 with numerous mandates pertaining to the medical devices ordinance (Medizinprodukteverordnung). Another growth area is digital health, where the team advises on digital health services and health apps, the latter particularly in the startup space. The transaction specialists focus on restructuring and reorganisation matters as well as instructions from pharmaceutical and medical device clients. Another key area is the hospital sector, including advice at the interface with employment and construction law. Oliver Kairies (Hanover), Cornelia Yzer (Berlin) and Denis Ullrich (Leipzig) head the team.


‘Denis Ullrich is a very competent and committed colleague who was available to me as a technically experienced contact in many matters from corporate law to pharmaceutical law and gave me valuable support in my work. In all joint projects, we have always been able to develop economically sensible and goal-oriented solutions for our company.’

The law firm and in particular the team around Oliver Kairies work together in a very trusting and transparent manner. The family and medium-sized environment in the law firm contributes to this. As a client, you always get the best team for the issue at hand. At the same time, internal structures do not represent any perceptible hurdles for the customer.’

Oliver Kairies and Hendrik Sehy are characterized by their proven industry expertise and very high level of legal competence. Added to this is her wealth of experience in specific cases of legal issues in the healthcare sector.

Key clients

Städtisches Klinikum Braunschweig gGmbH

IDT Biologika GmbH

AWO Bezirksverband Hannover e. V.

Stadt Köln

Universitätsmedizin Göttingen

Medizinische Hochschule Hannover

Universität Siegen

Kliniken des Landkreises Lörrach

ZytoService Beta GmbH

Klinikum Friedrichshafen GmbH


Klinikum Niederlausitz GmbH

Klinikum Burgenlandkreis GmbH

Work highlights

  • Comprehensive advice to the Ulm University Hospital on the acquisition of 50% of the shares in a university and rehabilitation clinic from Sana Kliniken AG.
  • Advising EK-UNICO GmbH on the strategic cooperation between the two purchasing groups EK-UNICO and Sana Purchasing & Logistics in order to achieve better procurement conditions for their hospitals.
  • Support for the district of Oberspreewald-Lausitz in conducting a structured bidding process to find a strategic partner for Klinikum Niederlausitz GmbH with two hospital locations in southern Brandenburg.

michels.pmks Rechtsanwälte

Cologne-based michels.pmks Rechtsanwälte specialises in advising hospitals, medical care centers and medical practices on medical law, but also represents other companies in the healthcare sector. Issues pertaining to inpatient care are handled by Kerrin Schillhorn, who jointly heads the team with Jens-Peter Jahn, who specialises in advice on outpatient care. Jannis Kamann, who joined as partner in January 2021, as well as Marcus Michels cover matters at the interface with employment law, including senior consultant contracts under physician contract law.

Other key lawyers:

Marcus Michels; Jannis Kamann


‘Kerrin Schillhorn is very committed and has many years of experience. Her in-depth legal knowledge and industry focus ensure successful consulting.’

‘Available at any time, quick contact and prompt as well as pragmatic assistance. Good knowledge of health insurance companies.’

‘Jens-Peter Jahn is always approachable and easily accessible. Quick solutions and he himself takes on every situation I find uncomfortable and solves it communicatively and/or legally.’

‘Concentrated expertise from a wide range of legal areas, which is of the greatest benefit to me. Advice from a single source increases efficiency.’

‘Kerrin Schillhorn: Proven expert in the fields of hospital planning and financing. I don’t know of anyone comparable. Very reliable and quick assessment of facts, so that I as a client can make clear decisions.’

Jens-Peter Jahn: Excellent expertise in medical law issues. Absolutely competent advice, especially in KV law, MVZs and takeovers.

Jannis Kamann: Very good, reliable and fast support in labor and social security law issues.

Key clients

Katholische Hospitalvereinigung Weser-Egge gGmbH

Krankenhaus Porz am Rhein GmbH

Kreisklinikum Siegen GmbH

Marien Gesellschaft Siegen gGmbH

MVZ am St. Marien-Hospital Friesoythe gGmbH

MVZ Karl Leisner Goch/Kevelaer/Geldern

MVZ des Universitätsklinikums Köln gGmbH

MVZ St. Marien GmbH

St. Franziskus-Stiftung Münster

St. Vinzenz Krankenhaus GmbH Köln

Universitätsklinikum Köln AöR

Vestische Caritas-Kliniken gGmbH

Work highlights

  • Comprehensive advice on hospital law and representation of the Catholic Hospital Association Weser-Egge gGmbH: Cooperation with residents and other service providers, application for geriatric rehabilitation, hospital planning and representation in claims for reimbursement by health insurance companies for complex flat rates according to BSG case law.
  • Comprehensive and strategic advice on hospital law for the St. Franziskus Foundation and its 15 hospitals with over 4,000 beds on hospital planning, basic issues, cooperation with the Tele-Stroke-Unit, legal issues in connection with the Covid-19 regulations, organizational requirements for hospitals.
  • Comprehensive legal advice on panel doctors to the MVZ St. Marien GmbH in the course of the takeover of further practices.


Noerr combines regulatory expertise with interfacing practices, in particularl IT and data protection, commercial, transactions and patent law. Fabian Badtke (Frankfurt) heads the group and is highly experienced in antitrust law and compliance, while Evelyn Schulz ‘s food law expertise in Dresden complements the advisory offering. In Munich, patent lawyer Armin Kühne made associate partner in January 2021.

Practice head(s):

Fabian Badtke

Key clients

Ada Health GmbH


Avista Capital


Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung u. Energie



Carl Zeiss

Cellex Cell Professionals GmbH

Dexcel Pharma

Dr. Smile

Fraunhofer Gesellschaft



Helios Kliniken

HG Medical Investment GmbH


KRKA / TAD Pharma



Sapio Group

Siemens Healthcare


Zimmer Biomet


Work highlights

  • Advising the Irish drug researcher ICON PLC on the acquisition of the American PRA Health Sciences, Inc. on the regulatory and EU law aspects of the takeover; Purchase price approximately $12 billion.
  • Preparation of a legal opinion for Carl Zeiss for the cloud-based collaboration between neuropathologists and surgeons; Creation of contract documentation/terms of use for clinical tests and market launch; Coordination of legal feasibility, especially in data protection law in other jurisdictions.
  • Representing the generics manufacturer TAD Pharma GmbH in an ongoing series of legal proceedings against the Japanese drug manufacturer Daiichi regarding the blood pressure control drug OlmeAmlo.


In 2020, Oppenhoff advised on medical cannabis and regulatory matters in the context of Covid-19, market access and reimbursement issues were a particular focus. In the pharmaceutical space, the key areas are M&A transactions and litigation. The firm also increasingly handles venture capital mandates, for example for healthcare startups, and also covers digitisation matters. Gabriele Fontane in Frankfurt leads the team.

Practice head(s):

Gabriele Fontane

Key clients

Aphria Inc.

Dr. August Wolff GmbH & Co. KG Arzneimittel

LR Health & Beauty Systems GmbH

Bristol-Myers Squibb

Johnson & Johnson

Evonik Industries AG

Shop Apotheke Europe N. V.

CC Pharma

Ecolog Deutschland


Work highlights

  • Comprehensive advice to Ecolog Deutschland GmbH / Ecocare on the operation of Covid-19 test centers such as airports, on public tenders and contracts to carry out Covid-19 tests for the public sector and on the operation of Covid-19 vaccination centers.
  • Advising Shop Apotheke Europe NV on various M&A projects, in particular comprehensive advice on the acquisition of SmartPatient GmbH.  
  • Full-service consulting for the German subsidiaries of Aphria Inc.

PPP Rechtsanwälte

PPP Rechtsanwälte focuses on the out- and inpatient sector since its formation in 2018. Healthcare constitutes the main focus but the team also covers interfacing matters pertaining to tax, employment, data protection and social security law. The support offered includes advice on all business stages of health service providers, such as planning and approval, cooperation agreements, procurement law issues as well as pharmacy, pharmaceutical and medical device law. The firm expanded since its formation, with offices in Düsseldorf, where managing partner Andreas Penner is based, Heilbrunn, Ingolstadt and Bergisch Gladbach.

Practice head(s):

Andreas Penner

Work highlights

  • Advising associations and over 50 hospital pharmacies in connection with the AvP insolvency.
  • Advising the business consultancy Sikomed, which specializes in dental practices, on more than ten transactions, including innovative contractual dentist law models.
  • Advice to the hospital association Rhineland eV on basic procedures in sales tax issues for hospital pharmacies.

Tsambikakis & Partner Rechtsanwälte

Tsambikakis & Partner Rechtsanwälte is highly experienced in medical criminal law. The boutique, which specialises in commercial criminal law, regularly advises service providers on medical law, compliance, medical criminal law and criminal tax law matters. The firm’s founders, Michael Tsambikakis and Daniela Etterer in Cologne, Thorsten Zebisch in Stuttgart and Volker Ettwig in Berlin are the four main contacts.

Practice head(s):

Michael Tsambikakis

Work highlights

  • Comprehensive advice to the board of a medical university on compliance issues.
  • Comprehensive advice to the legal department of a university clinic on complex issues of medical criminal law, in particular with regard to corruption in the healthcare sector.
  • Comprehensive advice on medical law and medical criminal law to a university hospital in East Germany on a situation in which a significant number of false reports were suspected by a head of the hospital.

von BOETTICHER Rechtsanwälte Partnerschaftsgesellschaft mbB

von BOETTICHER Rechtsanwälte Partnerschaftsgesellschaft mbB has experience in advising vaccine manufacturers and distributors and covers matters pertaining to pharmaceutical advertising law. Other key strengths are compliance and contract drafting, such as license and distribution agreements as well as research and development contracts. The team also advises startups on the design and marketing of new products and services, with additional interface expertise in transactions. Claudia Böhm (pharmaceutical and competition law), Oliver Stöckel (pharmaceutical and medical device law, HWG) in Munich and Anselm Brandi-Dohrn (pharmaceutical, IP, IT) in Berlin are the key figures.

Key clients


Belano Medical AG

Betterguards GmbH

CellAct Pharma GmbH

Cellbricks GmbH

EVER Neuro Pharma Gruppe

Gilead Sciences GmbH

LEO Pharma GmbH

Madaus & Lauscher GmbH

medithek GmbH

Nekonal SARL (Lux)

Polski Bank Komórek Macierzystych (PBKM)


Sedana Medical AB (publ)

Work highlights

  • Comprehensive advice to EVER Neuro Pharma GmbH on IP, UWG and pharmaceutical law, in particular clinical studies, licensing issues, supplier contracts; Representation in numerous disputes with a former exclusive distributor for market development in Germany and Switzerland as well as with other competitors.
  • Representing an international pharmaceutical group with a vaccine business in numerous competition law disputes with other vaccine suppliers regarding a high-dose flu vaccine.
  • Representing and advising Polski Bank Komórek Macierzystych (PBKM) on the acquisition of Eticur, a leading German provider of testing, processing and storage of umbilical cord blood stem cells.


The team at WilmerHale fields practice head Hans-Georg Kamann and special counsel Peter Gey (both active from Frankfurt and Brussels), and is thus well versed in interface matters such as data protection and antitrust law. The practice also has industry-specific know how. In addition to regulatory advice on clinical studies in the pharmaceutical and medical device sector and distribution law issues, the team also advises on certification issues for medical devices, which was of particular prominence in 2020. 

Practice head(s):

Hans-Georg Kamann

Other key lawyers:

Peter Gey

Key clients

Becton Dickinson GmbH

Bundesverband der pharmazeutischen Industrie (BPI e.V.)

Bundesinnung der Hörgeräteakustiker – biha

Danaher Corporation

IDEXX Europe B.V.

Institut Straumann AG

Karyopharm, Inc., Karyopharm Deutschland GmbH

Novaliq GmbH

Editas Medicine, Inc.

Work highlights

  • Advising the Federal Association of the Pharmaceutical Industry eV (BPI) on international data transfers in so-called third countries and on data protection issues in clinical studies and the current enforcement practice of the German data protection authorities and the EDPB.
  • Successful defending of Medtronic, Inc. in an IP litigation regarding a new highly innovative product.
  • Advising the Federal Guild of Hearing Aid Acousticians – biha on contractual issues and the law on the advertising of medicinal products (HWG) as well as social law/reimbursement law (SGB V) for hearing systems.